Copyright © 2005 Elsevier B.V. All rights reserved.
Protection against paracetamol-induced hepatic injury by prazosin pre-treatment in CD-1 mice
Received 29 September 2004;
References and further reading may be available for this article. To view references and further reading you must purchase this article.
Abstract
A synergistic depletion of glutathione has been suggested to be one critical factor in the hepatic injury in mice induced by non-toxic doses of paracetamol (APAP) when co-administered with α-adrenergic agonists. Prazosin (an α-adrenergic antagonist) could confer hepatoprotection following a toxic APAP dose (530 mg/kg) by increasing glutathione levels and enhancing bioinactivation by glucuronidation and glutathione conjugation. The effect of prazosin pre-treatment on APAP-induced gluthathione depletion and bioinactivation in vivo was assessed. Prazosin (15 mg/kg) pre-treatment provided protection against APAP-induced hepatic injury as evidenced by a significant decrease in serum transaminase (ALT) levels after 5 h (p < 0.05). Interestingly, prazosin pre-treatment did not prevent the dramatic depletion of glutathione by high dose APAP and it had no effect on the quantity of the glutathione conjugate formed. However, prazosin pre-treatment caused a significant increase in recovery of the administered dose (530 mg/kg) as the glucuronide metabolite (p < 0.05). UDP-glucuronosyltransferase (UGT) is involved in the bioinactivation of APAP by glucuronidation and we showed that prazosin had no effect on microsomal UGT kinetics. Thus, prazosin had no effect on either APAP-mediated glutathione depletion or the extent of APAP-glutathione conjugate formation and may be affecting other mechanisms to reduce oxidative stress caused by a toxic dose of APAP.
Keywords: Paracetamol; Prazosin; Glutathione; Glucuronidation
Article Outline
- 1. Introduction
- 2. Materials and methods
- 2.1. Animal dosing regimen (effect of prazosin pre-treatment on paracetamol toxicity)
- 2.2. Determination of serum alanine transaminase (ALT)
- 2.3. Determination of hepatic glutathione levels
- 2.4. Determination of the effect of prazosin pre-treatment on hepatic paracetamol glucuronide and glutathione conjugate at low and high dose
- 2.5. Microsome preparation and UDP-glucuronosyltransferase (UGT) kinetic studies
- 2.6. Statistical analysis
- 3. Results
- 3.1. Effect of prazosin pre-treatment on serum ALT and hepatic GSH with high dose paracetamol
- 3.2. Prazosin pre-treatment on hepatic paracetamol metabolism and UGT kinetics
- 4. Discussion
- Acknowledgements
- References






E-mail Article
Add to my Quick Links

Cited By in Scopus (2)







